Literature DB >> 23579325

The presenilin 1 P264L mutation presenting as non-fluent/agrammatic primary progressive aphasia.

Colin J Mahoney1, Laura E Downey, Jon Beck, Yuying Liang, Simon Mead, Richard J Perry, Jason D Warren.   

Abstract

Primary progressive aphasia (PPA) represents a diverse group of language-led dementias most often due to frontotemporal lobar degeneration. We report clinical, neuropsychological, and neuroimaging data in the case of a 47-year-old woman presenting with non-fluent PPA due to a genetically confirmed pathogenic Presenilin 1 P264L mutation. This case highlights an unusual clinical presentation of familial Alzheimer's disease and a novel presentation of the P264L mutation. The case adds to accumulating evidence that particular mutations can promote specific brain network degeneration, with wider implications for understanding the sporadic forms of Alzheimer's disease and PPA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23579325      PMCID: PMC4041608          DOI: 10.3233/JAD-122092

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  23 in total

1.  Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer's disease.

Authors:  M L Jacquemont; D Campion; V Hahn; C Tallaksen; T Frebourg; A Brice; A Durr
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

2.  Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques.

Authors:  Cecile Dumanchin; Isabelle Tournier; Cosette Martin; Mira Didic; Serge Belliard; Bertrand Carlander; François Rouhart; Charles Duyckaerts; Jean-François Pellissier; Jean Baptiste Latouche; Didier Hannequin; Thierry Frebourg; Mario Tosi; Dominique Campion
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

Review 3.  Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review.

Authors:  Harro Seelaar; Jonathan D Rohrer; Yolande A L Pijnenburg; Nick C Fox; John C van Swieten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-22       Impact factor: 10.154

Review 4.  Staging Alzheimer's disease progression with multimodality neuroimaging.

Authors:  Michael Ewers; Giovanni B Frisoni; Stefan J Teipel; Lea T Grinberg; Edson Amaro; Helmut Heinsen; Paul M Thompson; Harald Hampel
Journal:  Prog Neurobiol       Date:  2011-06-22       Impact factor: 11.685

5.  Familial semantic dementia with P301L mutation in the Tau gene.

Authors:  Takanori Ishizuka; Masayuki Nakamura; Mio Ichiba; Akira Sano
Journal:  Dement Geriatr Cogn Disord       Date:  2011-05-10       Impact factor: 2.959

6.  Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.

Authors:  G Raux; L Guyant-Maréchal; C Martin; J Bou; C Penet; A Brice; D Hannequin; T Frebourg; D Campion
Journal:  J Med Genet       Date:  2005-07-20       Impact factor: 6.318

Review 7.  Primary progressive aphasia: clinicopathological correlations.

Authors:  Murray Grossman
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

8.  A presenilin 1 R278I mutation presenting with language impairment.

Authors:  A K Godbolt; J A Beck; J Collinge; P Garrard; J D Warren; N C Fox; M N Rossor
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

9.  Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP.

Authors:  Rita Joao Guerreiro; Miquel Baquero; Rafael Blesa; Mercè Boada; Jose Miguel Brás; Maria J Bullido; Ana Calado; Richard Crook; Carla Ferreira; Ana Frank; Teresa Gómez-Isla; Isabel Hernández; Alberto Lleó; Alvaro Machado; Pablo Martínez-Lage; José Masdeu; Laura Molina-Porcel; José L Molinuevo; Pau Pastor; Jordi Pérez-Tur; Rute Relvas; Catarina Resende Oliveira; Maria Helena Ribeiro; Ekaterina Rogaeva; Alfredo Sa; Lluís Samaranch; Raquel Sánchez-Valle; Isabel Santana; Lluís Tàrraga; Fernando Valdivieso; Andrew Singleton; John Hardy; Jordi Clarimón
Journal:  Neurobiol Aging       Date:  2008-07-30       Impact factor: 4.673

10.  Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features.

Authors:  Colin J Mahoney; Jon Beck; Jonathan D Rohrer; Tammaryn Lashley; Kin Mok; Tim Shakespeare; Tom Yeatman; Elizabeth K Warrington; Jonathan M Schott; Nick C Fox; Martin N Rossor; John Hardy; John Collinge; Tamas Revesz; Simon Mead; Jason D Warren
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

View more
  4 in total

1.  Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases.

Authors:  Eliana Marisa Ramos; Deepika Reddy Dokuru; Victoria Van Berlo; Kevin Wojta; Qing Wang; Alden Y Huang; Sandeep Deverasetty; Yue Qin; Marka van Blitterswijk; Jazmyne Jackson; Brian Appleby; Yvette Bordelon; Patrick Brannelly; Danielle E Brushaber; Bradford Dickerson; Susan Dickinson; Kimiko Domoto-Reilly; Kelley Faber; Julie Fields; Jamie Fong; Tatiana Foroud; Leah K Forsberg; Ralitza Gavrilova; Nupur Ghoshal; Jill Goldman; Jonathan Graff-Radford; Neill Graff-Radford; Ian Grant; Murray Grossman; Hilary W Heuer; Ging-Yuek R Hsiung; Edward Huey; David Irwin; Kejal Kantarci; Anna Karydas; Daniel Kaufer; Diana Kerwin; David Knopman; John Kornak; Joel H Kramer; Walter Kremers; Walter Kukull; Irene Litvan; Peter Ljubenkov; Codrin Lungu; Ian Mackenzie; Mario F Mendez; Bruce L Miller; Chiadi Onyike; Alexander Pantelyat; Rodney Pearlman; Len Petrucelli; Madeline Potter; Katherine P Rankin; Katya Rascovsky; Erik D Roberson; Emily Rogalski; Leslie Shaw; Jeremy Syrjanen; Maria Carmela Tartaglia; Nadine Tatton; Joanne Taylor; Arthur Toga; John Q Trojanowski; Sandra Weintraub; Bonnie Wong; Zbigniew Wszolek; Rosa Rademakers; Brad F Boeve; Howard J Rosen; Adam L Boxer; Giovanni Coppola
Journal:  Alzheimers Dement       Date:  2020-01       Impact factor: 21.566

2.  Frontotemporal dementia spectrum: first genetic screen in a Greek cohort.

Authors:  Eliana Marisa Ramos; Christos Koros; Deepika Reddy Dokuru; Victoria Van Berlo; Christos Kroupis; Kevin Wojta; Qing Wang; Nikolaos Andronas; Stavroula Matsi; Ion N Beratis; Alden Y Huang; Suzee E Lee; Anastasios Bonakis; Chryseis Florou-Hatziyiannidou; Stella Fragkiadaki; Dionysia Kontaxopoulou; Dimitrios Agiomyrgiannakis; Vasiliki Kamtsadeli; Niki Tsinia; Vasiliki Papastefanopoulou; Maria Stamelou; Bruce L Miller; Leonidas Stefanis; John D Papatriantafyllou; Sokratis G Papageorgiou; Giovanni Coppola
Journal:  Neurobiol Aging       Date:  2018-11-03       Impact factor: 4.673

3.  Genetic screen in a large series of patients with primary progressive aphasia.

Authors:  Eliana Marisa Ramos; Deepika Reddy Dokuru; Victoria Van Berlo; Kevin Wojta; Qing Wang; Alden Y Huang; Zachary A Miller; Anna M Karydas; Eileen H Bigio; Emily Rogalski; Sandra Weintraub; Benjamin Rader; Bruce L Miller; Maria Luisa Gorno-Tempini; Marek-Marsel Mesulam; Giovanni Coppola
Journal:  Alzheimers Dement       Date:  2019-01-25       Impact factor: 21.566

4.  A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects.

Authors:  Juliana Acosta-Uribe; David Aguillón; Francisco Lopera; Kenneth S Kosik; J Nicholas Cochran; Margarita Giraldo; Lucía Madrigal; Bradley W Killingsworth; Rijul Singhal; Sarah Labib; Diana Alzate; Lina Velilla; Sonia Moreno; Gloria P García; Amanda Saldarriaga; Francisco Piedrahita; Liliana Hincapié; Hugo E López; Nithesh Perumal; Leonilde Morelo; Dionis Vallejo; Juan Marcos Solano; Eric M Reiman; Ezequiel I Surace; Tatiana Itzcovich; Ricardo Allegri; Raquel Sánchez-Valle; Andrés Villegas-Lanau; Charles L White; Diana Matallana; Richard M Myers; Sharon R Browning
Journal:  Genome Med       Date:  2022-03-08       Impact factor: 15.266

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.